Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma.

Autor: Kensler TW, Reck LJ, Cooney DA
Jazyk: angličtina
Zdroj: Cancer research [Cancer Res] 1981 Mar; Vol. 41 (3), pp. 905-9.
Databáze: MEDLINE